Anbio Biotechnology (NNNN) | Stock Overview & Key Data
Anbio Biotechnology Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $55.65 on July 15, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Anbio Biotechnology
NNNN
|
1.20B Small-cap | -2.38% | -37.60% | -22.96% | -40.81% | -42.98% | 80.02% | 170.19% | 170.19% | 170.19% | 170.19% | 170.19% |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -0.49% | -1.09% | -13.84% | -25.55% | -25.88% | -19.74% | 24.81% | 40.32% | 476.52% | 974.11% | 3,431.44% |
| 56.10B Large-cap | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% | |
|
Pulse Biosciences
PLSE
|
1.65B Small-cap | 4.35% | 5.58% | 18.74% | 83.44% | 93.58% | 54.53% | 288.68% | 40.54% | 457.67% | 490.07% | 490.07% |
|
AtriCure
ATRC
|
1.43B Small-cap | 3.94% | -0.50% | -8.08% | -31.82% | -28.75% | -8.95% | -40.16% | -61.38% | 94.66% | 127.41% | 234.77% |
|
Staar Surgical
STAA
|
1.23B Small-cap | -5.31% | -11.54% | 56.91% | 20.42% | 20.21% | 66.10% | -46.07% | -80.50% | 419.60% | 454.10% | 273.29% |
Ownership & Short Interest
Calculate Your Anbio Biotechnology Investment Returns
Long-Term Investment Performance Analysis
Anbio Biotechnology stock price in Feb 2025 was $5.77, A $1,000.00 lump sum investment in Anbio Biotechnology made 1 years ago would be worth approximately $2,913.34 today, representing a strong return of 191.33%. This translates to an annualized return (CAGR) of 124.48%.
1 Year 3 Months Investment Scenario (Feb 2025 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NNNN's 52-week high and low?
- In the last 52 weeks, Anbio Biotechnology reached a high of $55.65 (on July 15, 2025) and a low of $8.60 (on June 16, 2025).
- What is the market cap and P/E ratio for NNNN?
- Curious about Anbio Biotechnology's size and valuation? Its market capitalization stands at 1.20B. When it comes to valuation, the P/E ratio (trailing twelve months) is 181.00, and the forward P/E (looking ahead) is N/A.
- Does NNNN pay dividends? If so, what's the yield?
- As for dividends, Anbio Biotechnology isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Anbio Biotechnology's main competitors or similar companies to consider before investing?
When looking at Anbio Biotechnology, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -19.74% 24.81% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.01% -28.08% Pulse Biosciences
PLSE1.65B Healthcare Medical Instruments & Supplies 54.53% 288.68% AtriCure
ATRC1.43B Healthcare Medical Instruments & Supplies -8.95% -40.16% Staar Surgical
STAA1.23B Healthcare Medical Instruments & Supplies 66.10% -46.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Anbio Biotechnology Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Anbio Biotechnology's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 27.05%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NNNN?
- Looking at Anbio Biotechnology's growth, its revenue over the trailing twelve months (TTM) was $9M. Compared to the same quarter last year (YoY), quarterly revenue grew by 73.90%, and quarterly earnings saw a YoY growth of N/A.
- How much of NNNN stock is held by insiders and institutions?
- Wondering who owns Anbio Biotechnology stock? Company insiders (like executives and directors) hold about 4.78% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.85%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.